Australian company Actinogen Medical is developing a new drug — Xanamem that blocks the excess production of stress hormone cortisol in Alzheimer’s sufferers, offering a potential treatment for the disease.

Published in Health

VENDOR NEWS & EVENTS

REVIEWS

Recent Comments